R A Linker1, A Kroner, T Horn, R Gold, M Mäurer, M Bendszus. 1. Clinical Research Group for Multiple Sclerosis, Julius Maximilians-Universität Würzburg, Josef-Schneider-Strasse 11, 97080 Würzburg, Germany.
Abstract
BACKGROUND AND PURPOSE: The detection of cell infiltration is critical for the diagnosis and monitoring of inflammatory disorders, especially in the central nervous system (CNS). Superparamagnetic iron oxide (SPIO) particles have recently been introduced as a contrast agent to detect macrophage migration in vivo by MR imaging. We tested the hypothesis that focal hyperechogenicity due to SPIO-laden macrophages can also be visualized on high-resolution sonography. METHODS: Experimental autoimmune encephalomyelitis (EAE) was induced by myelin-oligodendrocyte glycoprotein (MOG) in congenic Lewis rats, an animal model mimicking many aspects of human multiple sclerosis. At the height of disease, rats underwent MR imaging with a 1.5T unit. Animals were injected with SPIO particles 24 hours before imaging. Control rats either received no contrast agent or were injected with SPIO particles without prior induction of EAE. Immediately after MR imaging, the rats were sacrificed, and the brains were removed and placed in saline. Sonography was performed directly after brain removal. Brains were embedded in paraffin, and sections were stained for iron with Perls stain and for macrophages with ED1 immunohistochemistry. RESULTS: SPIO-enhanced sonography of rat brains during a relapse of EAE specifically showed marked focal echogenicity in EAE-typical areas of the brain, including the periventricular region, the cerebellum, and the brain stem. The sonographic results corresponded to in vivo MR imaging findings of the respective animals as well to the clinical symptoms of EAE and to histology showing iron-laden macrophages in demyelinated lesions. CONCLUSION: SPIO particles allow the detection and demarcation of inflammatory CNS lesions on sonograms by specific macrophage imaging.
BACKGROUND AND PURPOSE: The detection of cell infiltration is critical for the diagnosis and monitoring of inflammatory disorders, especially in the central nervous system (CNS). Superparamagnetic iron oxide (SPIO) particles have recently been introduced as a contrast agent to detect macrophage migration in vivo by MR imaging. We tested the hypothesis that focal hyperechogenicity due to SPIO-laden macrophages can also be visualized on high-resolution sonography. METHODS: Experimental autoimmune encephalomyelitis (EAE) was induced by myelin-oligodendrocyte glycoprotein (MOG) in congenic Lewis rats, an animal model mimicking many aspects of human multiple sclerosis. At the height of disease, rats underwent MR imaging with a 1.5T unit. Animals were injected with SPIO particles 24 hours before imaging. Control rats either received no contrast agent or were injected with SPIO particles without prior induction of EAE. Immediately after MR imaging, the rats were sacrificed, and the brains were removed and placed in saline. Sonography was performed directly after brain removal. Brains were embedded in paraffin, and sections were stained for iron with Perls stain and for macrophages with ED1 immunohistochemistry. RESULTS:SPIO-enhanced sonography of rat brains during a relapse of EAE specifically showed marked focal echogenicity in EAE-typical areas of the brain, including the periventricular region, the cerebellum, and the brain stem. The sonographic results corresponded to in vivo MR imaging findings of the respective animals as well to the clinical symptoms of EAE and to histology showing iron-laden macrophages in demyelinated lesions. CONCLUSION:SPIO particles allow the detection and demarcation of inflammatory CNS lesions on sonograms by specific macrophage imaging.
Authors: V Dousset; L Ballarino; C Delalande; M Coussemacq; P Canioni; K G Petry; J M Caillé Journal: AJNR Am J Neuroradiol Date: 1999-02 Impact factor: 3.825
Authors: G Becker; A Krone; K Schmitt; M Woydt; E Hofmann; A Lindner; U Bogdahn; G Gahn; K Roosen Journal: Ultrasound Med Biol Date: 1995 Impact factor: 2.998
Authors: M K Storch; A Stefferl; U Brehm; R Weissert; E Wallström; M Kerschensteiner; T Olsson; C Linington; H Lassmann Journal: Brain Pathol Date: 1998-10 Impact factor: 6.508
Authors: M Adelmann; J Wood; I Benzel; P Fiori; H Lassmann; J M Matthieu; M V Gardinier; K Dornmair; C Linington Journal: J Neuroimmunol Date: 1995-12 Impact factor: 3.478
Authors: Christoph Kleinschnitz; Martin Bendszus; Marco Frank; Laszlo Solymosi; Klaus V Toyka; Guido Stoll Journal: J Cereb Blood Flow Metab Date: 2003-11 Impact factor: 6.200
Authors: Klara Kirschbaum; Jana K Sonner; Matthias W Zeller; Katrin Deumelandt; Julia Bode; Rakesh Sharma; Thomas Krüwel; Manuel Fischer; Angelika Hoffmann; Milene Costa da Silva; Martina U Muckenthaler; Wolfgang Wick; Björn Tews; John W Chen; Sabine Heiland; Martin Bendszus; Michael Platten; Michael O Breckwoldt Journal: Proc Natl Acad Sci U S A Date: 2016-10-31 Impact factor: 11.205
Authors: Yutong Liu; Mariano G Uberti; Huanyu Dou; Rebecca Banerjee; Cassi B Grotepas; David K Stone; Barrett E Rabinow; Howard E Gendelman; Michael D Boska Journal: J Neuroimmunol Date: 2008-07-24 Impact factor: 3.478
Authors: Andrew J Kwilasz; Madison A Clements; Tracey A Larson; Kevin M Harris; Scott T Litwiler; Brodie J Woodall; Laurel S Todd; Anouk E W Schrama; Eric H Mitten; Steven F Maier; Anne-Marie Van Dam; Kenner C Rice; Linda R Watkins Journal: Front Pain Res (Lausanne) Date: 2022-09-13